|
|
Article: Thermo Fisher Acquires Brahms AG - Analyst Blog
- Article from:
- Zacks Investment Research - Analyst Blog
- Article date:
- October 6, 2009
- Author:
CopyrightCopyright 2009 Zacks Investment Research. (Hide copyright information)
|
Thermo Fisher Acquires Brahms AG - Analyst Blog
Thermo Fisher Scientific Inc.
(
TMO
) recently completed the acquisition of Brahms AG for roughly $470 million (€330 million). Brahms AG is a leading provider of specialty in vitro diagnostic tests based on patented biomarkers for cardiovascular, sepsis and pulmonary diseases. The company also provides intensive care treatments and prenatal screening and is widely recognized for its flagship test, Procalcitonin (PCT).Â
The acquisition is expected to be accretive to Thermo Fisher’s earnings in 2010. The acquisition widens Thermo Fisher’s global reach and will increase its top-line. Brahms AG generated ...